Progress in the Care of Familial Hypercholesterolaemia: 2016


Familial hypercholesterolaemia (FH) is the most common autosomal dominant condition. FH reduces the catabolism of low-density lipoprotein cholesterol (LDL-c) and increases rates of premature atherosclerotic cardiovascular disease (CVD).

This module focuses on recent advances in the management of FH, and the implications for both primary and secondary care, noting that the majority of individuals with FH remain undiagnosed.


Learning Outcomes

  1. Be aware of the prevalence of familial hypercholesterolaemia (FH) and the key role for primary care in diagnostic and know the risk factors of untreated FH
  2. Identify the optimal time for detection of FH
  3. Acknowledge the important role of the community laboratory in identifying FH


Authors: Damon A Bell, Gerald F Watts

Article Type: Narrative review

Medical Journal of Australia
Reading: journal; textbook; book; literature review
1h : 0m
MBA: 1h : 0m
Cardiovascular Diseases
Medical Practitioner, Medical Student, Doctor-in-Training, Non-Vocationally Registered, Nurse / Midwife, Pharmacist, Researcher, Retired, Specialist - Other, Specialist General Practitioner
You have to be logged in to see the content of this module.

Provided by

doctorportal Learning respectfully acknowledges Aboriginal and Torres Strait Islander peoples as the first inhabitants of Australia. We respect the traditional owners of lands across Australia in which our members and staff work and live, and pay respect to their elders past, present and future.